−1000KRW
−77.77 BKRW
40.20 BKRW
71.17 M
About GENEONE
Sector
Industry
CEO
Young-Geun K. Park
Website
Headquarters
Seoul
Founded
1976
ISIN
KR7011000007
FIGI
BBG000BDV0K1
GeneOne Life Science, Inc. engages in the research, development, and manufacture of deoxyribonucleic acid (DNA) vaccines for the prevention and treatment of diseases. Its products include VGX-3400, VGX-3500, and fluorine. Its service includes process cost analysis, sterility testing, research batch production, strain selection, cell bank characterization, and others. It also conducts pre-clinical trials for the treatment of hepatitis C. In addition, it is involved in contract manufacturing activities for pre-clinical and clinical trials for companies and institutions. The company was founded on January 27, 1976 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 011000 is 2285 KRW — it has increased by 1.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENEONE stocks are traded under the ticker 011000.
011000 stock is 2.46% volatile and has beta coefficient of 0.96. Check out the list of the most volatile stocks — is GENEONE there?
Yes, you can track GENEONE financials in yearly and quarterly reports right on TradingView.
011000 stock has fallen by 1.93% compared to the previous week, the month change is a 9.15% fall, over the last year GENEONE has showed a 66.59% decrease.
011000 net income for the last quarter is −39.80 B KRW, while the quarter before that showed −11.56 B KRW of net income which accounts for −244.38% change. Track more GENEONE financial stats to get the full picture.
Today GENEONE has the market capitalization of 180.02 B, it has decreased by 3.62% over the last week.
No, 011000 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 011000 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENEONE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENEONE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENEONE stock shows the sell signal. See more of GENEONE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENEONE EBITDA is −35.66 B KRW, and current EBITDA margin is −88.53%. See more stats in GENEONE financial statements.